## Abstract ## BACKGROUND The authors assessed the biologic behavior of differentiated thyroid carcinoma in patients age 70 years or older and evaluated factors that influenced long‐term survival. ## METHODS Among 1448 patients with differentiated thyroid carcinoma who were treated at the author
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
✍ Scribed by Maurice Tubiana; Martin Schlumberger; Philippe Rougier; Agnès Laplanche; Ellen Benhamou; Paule Gardet; Bernard Caillou; Jean-Paul Travagli; Claude Parmentier
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 924 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Approximately 20% of patients with thyroid carcinoma have relapse. To evaluate the factors affecting their disease-free survival and prognosis, we studied 68 patients with recurrent differentiated thyroid carcinoma, ranging in age from 5 to 73 years (mean: 47.6 years). Threefourths of pa
Differentiated thyroid carcinoma (DTC) is usually an indolent tumor associated with a low mortality. However, DTC, particularly papillary thyroid carcinoma, happens to be a multicentric tumor and tends to spread to the regional lymph nodes in the early stage of the disease; some patients with DTC do
For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is in some centers considered a first-line therapeutic option. However, such a strategy is still under debate with regard to tumor and patient characteristics. In this single-center study we assessed the 5-year
## Background and objectives: The clinical characteristics and patient outcome of a group of patients treated for differentiated thyroid carcinoma (dtc) were analyzed in order to assess the relative influence of different prognostic factors. ## Materials and methods: We retrospectively reviewed d